Wnt Agonist I

2,4-Pyrimidinediamine, N~4~-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)-

853220-52-7

N4-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine

N~4~-(1,3-Benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)-2,4-pyrimidindiamin

N~4~-(1,3-Benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)-2,4-pyrimidinediamine

N~4~-(1,3-Benzodioxol-5-ylméthyl)-6-(3-méthoxyphényl)-2,4-pyrimidinediamine

Wnt Agonist I

2,4-Pyrimidinediamine, N4-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)-

2-Amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine

2-Amino-4-[[3,4-(methylenedioxy)benzyl]amino]-6-(3-methoxyphenyl)pyrimidine

4-N-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine

BML 284;BML284

MFCD09908087

N4-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)-2,4-pyrimidinediamine

N4-(2H-1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine

N4-(benzo[d][1,3]dioxol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine

N4-[(2H-1,3-benzodioxol-5-yl)methyl]-6-(3-methoxyphenyl)pyrimidine-2,4-diamine

Wnt Agonist

wnt agonist 1 (bml-284)

wnt agonist 1(bml-284)